These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32999785)

  • 1. A Case Report on Bortezomib-Induced Bilateral Chalazion.
    Paravathaneni M; Thota V; Mulla S; Thirumaran R; Thar YY
    Cureus; 2020 Aug; 12(8):e10062. PubMed ID: 32999785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalazion in a patient with multiple myeloma treated with bortezomib.
    Ghimire B; Hamajima Y; Carbajal-Carballo L; Anusim N
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36593601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series.
    Sklar BA; Gervasio KA; Leng S; Ghosh A; Chari A; Wu AY
    BMC Ophthalmol; 2019 May; 19(1):110. PubMed ID: 31088416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Bortezomib Therapy and Eyelid Chalazia.
    Fraunfelder FW; Yang HK
    JAMA Ophthalmol; 2016 Jan; 134(1):88-90. PubMed ID: 26469392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy.
    Yun C; Mukhi N; Kremer V; Shinder R; Verma V; Olcay B
    Hematol Rep; 2015 Jun; 7(2):5729. PubMed ID: 26330998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4-related disease mimicking chalazion in the upper eyelid with skin manifestations on the trunk.
    Leivo T; Koskenmies S; Uusitalo M; Tynninen O
    Int Ophthalmol; 2015 Aug; 35(4):595-7. PubMed ID: 25834990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular rosacea without facial erythema involvement manifesting as bilateral multiple recurrent chalazions: A case report.
    Han XM; Zhou YM; Cen LS
    World J Clin Cases; 2024 Jun; 12(17):3253-3258. PubMed ID: 38898849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extratarsal presentation of chalazion.
    Chang M; Park J; Kyung SE
    Int Ophthalmol; 2017 Dec; 37(6):1365-1367. PubMed ID: 27942990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalazion as a cause of decreased vision after LASIK.
    Cosar CB; Rapuano CJ; Cohen EJ; Laibson PR
    Cornea; 2001 Nov; 20(8):890-2. PubMed ID: 11685074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
    Grannis CH; Dewan VN; Wang RC
    Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of early relapse of ocular myeloma with bortezomib and steroid after autologous stem cell transplantation.
    Yavasoglu I; Kocaturk T; Kadikoylu G; Dayanir V; Dayanir Y; Bolaman Z
    Bratisl Lek Listy; 2010; 111(12):670-2. PubMed ID: 21384738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspected spinocellular carcinoma of the inferior eyelid resulted multiple chalazion.
    Onesti MG; Troccola A; Maruccia M; Conversi A; Scuderi G
    Ann Ital Chir; 2013; 84(ePub):. PubMed ID: 23343591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular complication of intralesional corticosteroid injection of a chalazion.
    Hoşal BM; Zilelioğlu G
    Eur J Ophthalmol; 2003; 13(9-10):798-9. PubMed ID: 14700103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphoma of the eyelid.
    Ishikawa M; Watabe H; Hayakawa M; Yoshitomi T
    Clin Ophthalmol; 2009; 3():527-9. PubMed ID: 19789662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib-induced severe pulmonary complications in multiple myeloma: A case report and literature review.
    Li J; Chen S; Hu Y; Cai J
    Oncol Lett; 2016 Mar; 11(3):2255-2260. PubMed ID: 26998158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging meibomian glands on a patient with chalazia in the upper and lower lids: a case report.
    Srinivasan S; Menzies KL; Sorbara L; Jones LW
    Cont Lens Anterior Eye; 2013 Aug; 36(4):199-203. PubMed ID: 23541979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular demodicidosis as a risk factor of adult recurrent chalazion.
    Yam JC; Tang BS; Chan TM; Cheng AC
    Eur J Ophthalmol; 2014; 24(2):159-63. PubMed ID: 23873491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chalazia associated with bortezomib therapy.
    Laaribi N; Abdellaoui T; Abaloun Y; Fiqhi A; Rabii H; Haidouri S; Mouzari Y; El Asri F; Reda K; Oubaaz A
    J Fr Ophtalmol; 2018 Oct; 41(8):e381-e382. PubMed ID: 30172381
    [No Abstract]   [Full Text] [Related]  

  • 19. Bortezomib ocular toxicities: Outcomes with ketotifen.
    Dennis M; Maoz A; Hughes D; Sanchorawala V; Sloan JM; Sarosiek S
    Am J Hematol; 2019 Mar; 94(3):E80-E82. PubMed ID: 30575098
    [No Abstract]   [Full Text] [Related]  

  • 20. Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: A case report.
    Lemoine J; Bonnin A; Marjanovic Z; van de Wyngaert Z; Ikhlef S; Alsuliman T; M'Hammedi-Bouzina F; Mohty M; Malard F
    Curr Res Transl Med; 2021 May; 69(2):103283. PubMed ID: 33639586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.